Jean-François Gestin

8PUBLICATIONS
31CO-AUTHORS
Instruments and techniquesMetal organic frameworksMetal cluster chemistryMolecular targetsSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 28, 2026
211At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges.

|Jul 17, 2025
Bambusuril as an effective astatide sequestrating agent by hydrogen bonding.

Clémence Maingueneau, Julie Patissou, Marine Lafosse

|May 11, 2025
Formation Of Gold-Astatine Bonds in N-Heterocyclic Carbene Complexes.

Mathilde Ligeour, Sébastien G Guillet, Clémence Maingueneau

|Apr 14, 2025
Preclinical and Clinical Feasibility Studies as the First Step Before Forthcoming Intravesical Instillation of [211At]At-anti-CA-IX Antibody (ATO-101™) Study in Patients with Non-Muscle-Invasive Bladder Cancer Unresponsive to Standard of Care.

Caroline Rousseau, Pierre Baumgartner, Marie-Françoise Heymann

|Oct 04, 2024
Astatine-211 radiolabelling chemistry: from basics to advanced biological applications.

Maarten Vanermen, Mathilde Ligeour, Maria-Cristina Oliveira

|Dec 29, 2021
211 At and 125 I-Labeling of (Hetero)Aryliodonium Ylides: Astatine Wins Again.

Clémence Maingueneau, Marion Berdal, Romain Eychenne

Pageof 2

Frequent Collaborators

7 joint publications

François Guérard

4 joint publications

Romain Eychenne

4 joint publications

Michel Chérel

3 joint publications

Clémence Maingueneau